237 related articles for article (PubMed ID: 27498059)
1. Sclerostin expression in skeletal sarcomas.
Shen J; Meyers CA; Shrestha S; Singh A; LaChaud G; Nguyen V; Asatrian G; Federman N; Bernthal N; Eilber FC; Dry SM; Ting K; Soo C; James AW
Hum Pathol; 2016 Dec; 58():24-34. PubMed ID: 27498059
[TBL] [Abstract][Full Text] [Related]
2. Rat Osteosarcoma Cells as a Therapeutic Target Model for Osteoregeneration via Sclerostin Knockdown.
Sedaghati B; Jahroomishirazi R; Starke A; Hacker MC; Schulz-Siegmund M
Cells Tissues Organs; 2016; 201(5):366-79. PubMed ID: 27233518
[TBL] [Abstract][Full Text] [Related]
3. Measurement of total and local bone morphogenetic protein concentration in bone tumours.
Laitinen M; Jortikka L; Halttunen T; Nevalainen J; Aho AJ; Marttinen A; Lindholm TS
Int Orthop; 1997; 21(3):188-93. PubMed ID: 9266301
[TBL] [Abstract][Full Text] [Related]
4. NELL-1 expression in benign and malignant bone tumors.
Shen J; LaChaud G; Khadarian K; Shrestha S; Zhang X; Soo C; Ting K; Dry SM; James AW
Biochem Biophys Res Commun; 2015 May; 460(2):368-74. PubMed ID: 25791475
[TBL] [Abstract][Full Text] [Related]
5. Effects of SOST Gene Silencing on Proliferation, Apoptosis, Invasion, and Migration of Human Osteosarcoma Cells Through the Wnt/β-Catenin Signaling Pathway.
Zou J; Zhang W; Li XL
Calcif Tissue Int; 2017 Jun; 100(6):551-564. PubMed ID: 28246931
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of GSK3β Stimulates BMP Signaling and Decreases SOST Expression Which Results in Enhanced Osteoblast Differentiation.
Schoeman MA; Moester MJ; Oostlander AE; Kaijzel EL; Valstar ER; Nelissen RG; Löwik CW; de Rooij KE
J Cell Biochem; 2015 Dec; 116(12):2938-46. PubMed ID: 26095393
[TBL] [Abstract][Full Text] [Related]
7. Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway.
Kim RY; Yang HJ; Song YM; Kim IS; Hwang SJ
Tissue Eng Part A; 2015 Jul; 21(13-14):2076-88. PubMed ID: 25837159
[TBL] [Abstract][Full Text] [Related]
8. Bone- and cartilage-forming tumors and ewing sarcoma: an update with a gnathic emphasis.
Stewart BD; Reith JD; Knapik JA; Chi AC
Head Neck Pathol; 2014 Dec; 8(4):454-62. PubMed ID: 25409851
[TBL] [Abstract][Full Text] [Related]
9. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
Machado I; Navarro S; Picci P; Llombart-Bosch A
Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
[TBL] [Abstract][Full Text] [Related]
10. The effect of TNFα secreted from macrophages activated by titanium particles on osteogenic activity regulated by WNT/BMP signaling in osteoprogenitor cells.
Lee SS; Sharma AR; Choi BS; Jung JS; Chang JD; Park S; Salvati EA; Purdue EP; Song DK; Nam JS
Biomaterials; 2012 Jun; 33(17):4251-63. PubMed ID: 22436801
[TBL] [Abstract][Full Text] [Related]
11. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM
J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675
[TBL] [Abstract][Full Text] [Related]
12. Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors.
Dancer JY; Henry SP; Bondaruk J; Lee S; Ayala AG; de Crombrugghe B; Czerniak B
Hum Pathol; 2010 Dec; 41(12):1788-93. PubMed ID: 21078438
[TBL] [Abstract][Full Text] [Related]
13. β-catenin is a valuable marker for differential diagnosis of osteoblastoma and osteosarcoma.
Wan Y; Zhao W; Jiang Y; Liu D; Meng G; Cai Y
Hum Pathol; 2014 Jul; 45(7):1459-65. PubMed ID: 24746516
[TBL] [Abstract][Full Text] [Related]
14. Osteogenic tumors of bone.
Green JT; Mills AM
Semin Diagn Pathol; 2014 Jan; 31(1):21-9. PubMed ID: 24680179
[TBL] [Abstract][Full Text] [Related]
15. Successful induction of sclerostin in human-derived fibroblasts by 4 transcription factors and its regulation by parathyroid hormone, hypoxia, and prostaglandin E2.
Fujiwara M; Kubota T; Wang W; Ohata Y; Miura K; Kitaoka T; Okuzaki D; Namba N; Michigami T; Kitabatake Y; Ozono K
Bone; 2016 Apr; 85():91-8. PubMed ID: 26851122
[TBL] [Abstract][Full Text] [Related]
16. Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis.
Ohyama Y; Nifuji A; Maeda Y; Amagasa T; Noda M
Endocrinology; 2004 Oct; 145(10):4685-92. PubMed ID: 15217980
[TBL] [Abstract][Full Text] [Related]
17. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours.
Conner JR; Hornick JL
Histopathology; 2013 Jul; 63(1):36-49. PubMed ID: 23701429
[TBL] [Abstract][Full Text] [Related]
18. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Umezu H; Sugai M; Endo N
Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
[TBL] [Abstract][Full Text] [Related]
19. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
20. Low sirtuin 1 levels in human osteoarthritis subchondral osteoblasts lead to abnormal sclerostin expression which decreases Wnt/β-catenin activity.
Abed É; Couchourel D; Delalandre A; Duval N; Pelletier JP; Martel-Pelletier J; Lajeunesse D
Bone; 2014 Feb; 59():28-36. PubMed ID: 24184155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]